Page 8 - MSM Campaign Council Webinar - June 2021

ADVANCING HEALTH EQUITY | PHARMACEUTICAL PARTNERSHIPS

James W. Lillard, Jr., PhD, MBA Dr. Lillard joined MSM’s faculty as Professor of Microbiology,

Entrepreneur in Residence | National Academy of Inventors Fellow Biochemistry & Immunology and Assistant Dean for Research. In July
American Association for the Advancement of Science Fellow 2011, Dr. Lillard established the Office of Translational Technologies at
44 h-index | 75 i10-index MSM, where he serves as its Director. Since 2018, he has served as the
Program Director of the online MS in Biotechnology program at MSM,
AcademicAppointments which is now ranked #1 out of 139 similar programs by Intelligent.com. He is
Associate Dean for Research Affairs, Morehouse School ofMedicine the Program Director of the online MS in Health Informatics program. Dr.
PI, AACR President’s 2020 by 2020 Initiative & Total Cancer Care Protocol Lillard serves as the Director of the Georgia Research Alliance Ventures
MPI, NCI U54 MSM/TU/UAB CCC Partnership Program and Associate Dean for Research Affairs at Morehouse School of
Director, OTT & GRA Ventures at Morehouse School of Medicine Medicine. He has helped establish biotechcompanies and contributed to
Director, online MS Biotechnology and MS Health Informatics Programs the formation and commercialization plans of others, as scientific and
Professor, Microbiology, Biochemistry & Immunology business advisor and/or founder.
IndustryAppointments ResearchInterests
President & CEO, JYANT Technologies, Inc. Dr. Lillard is an immuno-biologist who uses both in silico and in vivo methods to develop biologics and
Scientific Advisor, WellesleyPharmaceuticals, Inc.
Board of Advisors – Member, DevMar Manufacturing, Inc. other technologies to diagnose, prevent, and/or treat cancer and infectious diseases.
Scientific Medical Advisory Board – Ciitizen Corporation
Most recently, his laboratory research involves dissecting G protein-coupled receptors effects on cancers
James Lillard completed his B.S. degree in Electrical Engineering & Computer Science from the progression and immunity. James is the principal investigator of the Total Cancer Care protocol, which
Ohio State University and worked as a product development engineer for IBM. He received his Ph.D. aggregates and analyzes clinically annotated WGS/WES/WTS data from African American cancer
in Microbiology & Immunology from the University of Kentucky School of Medicine, where he patients/survivors to generate medical reports and identify new drug targets and diagnostic markers,
studied Yersinia “plague” pathogenesis. Dr. Lillard completed post-doctoral training in mucosal making it the largest initiative of its kind. His research contributions span multiple disciplines including
immunology at the University of Alabama at Birmingham. He has worked as an Assistant, Associate, oncology, vaccine development, and biodefense.
and now Full Professor in the Department of Microbiology,Biochemistry, and Immunology at
Morehouse School of Medicine, University of Louisville School of Medicine, and completed an Dr. Lillard’s cumulative peer-reviewed funding principally directed over his scientific career exceeds $55
Executive MBA from the Goizueta BusinessSchoolatEmoryUniversitywithafocuson million and he has authored over 300 scientific communications, which have been cited over 8,400
Biotechnology. times. Dr. Lillard’s articles have appeared in International Journal of Cancer Research, Clinical Cancer
Research, Journal of Clinical Investigations, Journal Immunology, Laboratory Investigations, and
LeadershipRoles Proceedings of the National Academy of Sciences USA. His work is well-recognized as indicated by his
Dr. Lillard was the Smith & Lucille Gibson Endowed Chair in Medicine, Senior Scientist at the appointment as a NAI Fellow, AAAS Fellow, and service on editorial boards and scientific review for the
James Graham Brown Cancer Center, and Vice Chair for Research & Professor in the NIH, VA, DoD, US FDA, industry advisory panels and studysections.
Department of Microbiology & Immunology at the University of Louisville.
msmimpact.org